More specifically, given that MYC drives the glucose and glutamine metabolism of cancer cells, the use of small molecules, able to inhibit enzymes involved in glycolysis and glutaminolysis, might be effective in slowing down tumor cell proliferation. Here, MYC is linked to neoplasm.